ImmuCell Corporation (ICCC)
NASDAQ: ICCC
· Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT
ImmuCell Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 0.01 | 22.34 | -10.56 | -5.69 | -23.06 | -8.65 | -11 | -6.94 | -4.3 | -7.08 | -22.12 | -24.14 | 25.39 | 205.81 | 122.60 | 128.90 | -39.43 |
PEG Ratio | 0.00 | -0.13 | 0.19 | -0.02 | 0.37 | -0.35 | 0.33 | 0.17 | -0.12 | -0.04 | 3.69 | 0.12 | 0.03 | -4 | n/a | -0.97 | 0.13 |
PS Ratio | 0.01 | 5.94 | 4.93 | 6.36 | 5.56 | 7.74 | 7.67 | 10.85 | 11.55 | 12.08 | 12.08 | 17.11 | 12.45 | 11.25 | 14.07 | 16.02 | 16.94 |
PB Ratio | 1.48 | 1.67 | 1.12 | 1.49 | 1.64 | 1.58 | 1.59 | 1.43 | 1.41 | 1.56 | 1.81 | 2.02 | 2.24 | 1.88 | 2.23 | 2.25 | 2.50 |
P/FCF Ratio | 0.03 | -230.92 | -40.72 | 73.95 | 115.99 | -49.04 | -44.56 | -27.57 | -11.56 | -16.95 | -29.08 | -115.93 | -442.18 | -525.01 | -174.02 | -489.92 | -71.54 |
P/OCF Ratio | 0.03 | -15.08K | -46.36 | 59.87 | 96.49 | -54.56 | -81.47 | -56.24 | -14.42 | -36.41 | -46.06 | 176.88 | 117.00 | 104.22 | 279.79 | 99.55 | -111.61 |
OCF/S Ratio | 0.20 | -0.00 | -0.11 | 0.11 | 0.06 | -0.14 | -0.09 | -0.19 | -0.8 | -0.33 | -0.26 | 0.10 | 0.11 | 0.11 | 0.05 | 0.16 | -0.15 |
Debt / Equity Ratio | 0.51 | 0.55 | 0.59 | 0.68 | 0.66 | 0.67 | 0.64 | 0.56 | 0.47 | 0.41 | 0.40 | 0.36 | 0.36 | 0.32 | 0.32 | 0.32 | 0.38 |
Quick Ratio | 2.21 | 1.80 | 1.44 | 0.77 | 0.97 | 0.87 | 1.38 | 0.81 | 1.54 | 2.59 | 4.09 | 5.07 | 6.32 | 5.20 | 6.19 | 6.45 | 4.62 |
Current Ratio | 4.12 | 3.41 | 3.11 | 2.37 | 2.68 | 2.73 | 3.59 | 2.61 | 3.19 | 4.56 | 6.05 | 6.91 | 7.78 | 6.42 | 7.42 | 7.64 | 5.63 |
Asset Turnover | 176.83 | 0.17 | 0.14 | 0.13 | 0.17 | 0.12 | 0.12 | 0.08 | 0.08 | 0.09 | 0.10 | 0.08 | 0.13 | 0.12 | 0.12 | 0.10 | 0.10 |
Interest Coverage | n/a | 4.96 | -4.31K | -9.74 | -2.06 | n/a | -8.19 | -14.73 | -25.07 | -17.45 | -6.9 | -6.57 | 10.54 | 1.89 | 3.45 | 2.71 | -4.7 |
Return on Equity | 49.91 | 0.02 | -0.03 | -0.07 | -0.02 | -0.05 | -0.04 | -0.05 | -0.08 | -0.05 | -0.02 | -0.02 | 0.02 | n/a | n/a | n/a | -0.02 |
Return on Assets | 31.72 | 0.01 | -0.02 | -0.04 | -0.01 | -0.03 | -0.02 | -0.03 | -0.05 | -0.04 | -0.01 | -0.01 | 0.02 | n/a | n/a | n/a | -0.01 |
Return on Invested Capital | 25.57 | 0.01 | -0.05 | -0.04 | -0.01 | -0.02 | -0.03 | -0.03 | -0.05 | -0.04 | -0.01 | -0.01 | 0.02 | n/a | 0.01 | 0.01 | -0.01 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.42 | 0.37 | 0.26 | 0.22 | 0.32 | 0.25 | 0.23 | 0.30 | 0.09 | 0.25 | 0.38 | 0.44 | 0.52 | 0.47 | 0.47 | 0.46 | 0.39 |
Net Profit Margin | 0.18 | 0.07 | -0.12 | -0.28 | -0.06 | -0.22 | -0.17 | -0.39 | -0.67 | -0.43 | -0.14 | -0.18 | 0.12 | 0.01 | 0.03 | 0.03 | -0.11 |
Pretax Profit Margin | 0.18 | 0.07 | -0.12 | -0.28 | -0.06 | -0.22 | -0.17 | -0.39 | -0.67 | -0.43 | -0.14 | -0.18 | 0.12 | 0.01 | 0.03 | 0.03 | -0.11 |
Operating Profit Margin | 0.14 | 0.08 | -95.63 | -0.25 | -0.04 | -0.2 | -0.22 | -0.37 | -0.65 | -0.42 | -0.13 | -0.15 | 0.13 | 0.03 | 0.05 | 0.05 | -0.09 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.14 | 0.17 | -95.63 | -0.13 | 0.05 | -0.06 | -0.02 | -0.17 | -0.45 | -0.25 | 0.01 | 0.01 | 0.24 | 0.14 | 0.17 | 0.19 | 0.06 |